Robust estimates of regional treatment effects in multiregional randomized clinical trials with semiparametric logistic model
- 4 August 2021
- journal article
- research article
- Published by Wiley in Pharmaceutical Statistics
- Vol. 21 (1) , 133-149
Abstract
In multiregional randomized clinical trials (MRCTs), determining the regional treatment effect of a new treatment over an existing one is important to both the sponsor and related regulatory agencies. Also of particular interest is to test the null hypothesis that the treatment benefit is the same among all the regions. Existing methods are mainly for continuous endpoint and use parametric models, which are not robust. MRCTs are known for facing increased variation and heterogeneity and a robust model for its design and analysis would be desirable. We consider clinical trials with a binary primary endpoint and propose a robust semiparametric logistic model which has a known parametric and an unknown nonparametric component. The parametric component represents our prior knowledge about the model, and the nonparametric part reflects uncertainty. Compared to the classic logistic model for this problem, the proposed model has the following advantages: robust to model assumption, more flexible and accurate to model the relationship between the response and covariates, and possibly more accurate parameter estimates. The model parameters are estimated by profile maximum likelihood approach, and the null hypothesis of regional treatment difference being the same is tested by the profile likelihood ratio statistic. Asymptotic properties of the estimates are derived. Simulation studies are conducted to evaluate the performance of the proposed model, which demonstrated clear advantages over the classic logistic model. The method is then applied to analyzing a real MRCT.Keywords
This publication has 21 references indexed in Scilit:
- Design and Sample Size Considerations for Simultaneous Global Drug Development ProgramJournal of Biopharmaceutical Statistics, 2012
- Multi‐regional clinical trials – What are the challenges?Pharmaceutical Statistics, 2010
- Assessing consistent treatment effect in a multi‐regional clinical trial: a systematic reviewPharmaceutical Statistics, 2010
- Consideration of regional difference in design and analysis of multi‐regional trialsPharmaceutical Statistics, 2010
- Sample Size Allocation to Regions in a Multiregional TrialJournal of Biopharmaceutical Statistics, 2009
- Continental Differences in Clinical Characteristics, Management, and Outcomes in Patients Hospitalized With Worsening Heart FailureJACC, 2008
- Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes. Results from PURSUITEuropean Heart Journal, 2000
- CONTINUOUS AND GROUP SEQUENTIAL CONDITIONAL PROBABILITY RATIO TESTS FOR PHASE II CLINICAL TRIALSStatistics in Medicine, 1996
- Profile Likelihood and Conditionally Parametric ModelsThe Annals of Statistics, 1992
- The Large-Sample Distribution of the Likelihood Ratio for Testing Composite HypothesesThe Annals of Mathematical Statistics, 1938